First Trust Advisors
KRTX

First Trust Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

First Trust Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,020
Closed -$3.17M – 2439
2023
Q4 		$3.17M Sell
10,020
-51,109
-84% -$9.93M ﹤0.01% 1524
2023
Q3 		$10.3M Buy
61,129
+54,095
+769% +$10.2M 0.01% 977
2023
Q2 		$1.53M Sell
7,034
-8,074
-53% -$1.73M ﹤0.01% 1836
2023
Q1 		$2.74M Buy
15,108
+6,194
+69% +$1.18M ﹤0.01% 1550
2022
Q4 		$1.75M Sell
8,914
-3,991
-31% -$856K ﹤0.01% 1750
2022
Q3 		$2.9M Buy
+12,905
New +$2.61M ﹤0.01% 1480
2021
Q4 		– Sell
-74,241
Closed -$9.08M – 2616
2021
Q3 		$9.08M Buy
74,241
+28,691
+63% +$3.31M 0.01% 1033
2021
Q2 		$5.19M Buy
45,550
+15,553
+52% +$1.82M 0.01% 1337
2021
Q1 		$3.61M Buy
+29,997
New +$3.4M ﹤0.01% 1442
2020
Q3 		– Sell
-30,860
Closed -$3.44M – 2516
2020
Q2 		$3.44M Buy
30,860
+1,160
+4% +$101K 0.01% 1126
2020
Q1 		$2.14M Buy
+29,700
New +$2.54M ﹤0.01% 1236

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

First Trust Advisors's KRTX Position: Q1 2024 in Review

First Trust Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 10,020 shares — an estimated $3.17M sold.

First Trust Advisors first reported a position in KRTX in Q1 2020 and held it in 11 quarters. The position peaked at $10.3M in Q3 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • First Trust Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • First Trust Advisors sold 10,020 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.17M.
  • First Trust Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • First Trust Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $10.3M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on First Trust Advisors's 13F filing for Q1 2024, filed 13 May 2024.